nach oben

Intensive Care Medicine

Erschienen in:

25.10.2017 | What's New in Intensive Care

Adjuvant therapies in critical care: steroids in community-acquired pneumonia

verfasst von: Antoni Torres, Miquel Ferrer, Michael S. Niederman

Erschienen in: Intensive Care Medicine | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Excerpt

Severe community-acquired pneumonia (CAP) is present in up to 19% of hospitalized patients with CAP and still carries a high morbidity and mortality. A French multicentre study of severe pneumococcal CAP patients admitted to intensive care units (ICU) reported an overall mortality rate of 29% [1]. The high mortality of severe CAP occurs despite the fact that the majority of patients receive an early and adequate antibiotic treatment. This is probably due, in part, to an imbalanced and disproportionate local and systemic inflammatory response that contributes to impairment of gas exchange, sepsis and end-organ dysfunction. …

Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, Cariou A, Chiche JD, Bedos JP, Mira JP (2012) Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit Care 16:R155CrossRefPubMedPubMedCentral

Monton C, Ewig S, Torres A, El Ebiary M, Filella X, Rano A, Xaubet A (1999) Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 14:218–220CrossRefPubMed

Sibila O, Luna CM, Agusti C, Baquero S, Gando S, Patron JR, Morato JG, Absi R, Bassi N, Torres A (2008) Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J 32:1037–1046CrossRefPubMed

Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della PR, Giorgio C, Blasi F, Umberger R, Meduri GU (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171:242–248CrossRefPubMed

Siempos II, Vardakas KZ, Kopterides P, Falagas ME (2008) Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother 62:661–668CrossRefPubMed

Nie W, Zhang Y, Cheng J, Xiu Q (2012) Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One 7:e47926CrossRefPubMedPubMedCentral

Cheng M, Pan ZY, Yang J, Gao YD (2014) Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis. Respir Care 59:557–563CrossRefPubMed

Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, Alexander PE, Fei Y, Vandvik PO, Loeb M, Guyatt GH (2015) Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med 163(7):519–528CrossRefPubMed

Horita N, Otsuka T, Haranaga S, Namkoong H, Miki M, Miyashita N, Higa F, Takahashi H, Yoshida M, Kohno S, Kaneko T (2015) Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Sci Rep 5:14061CrossRefPubMedPubMedCentral

10.

Marti C, Grosgurin O, Harbarth S, Combescure C, Abbas M, Rutschmann O, Perrier A, Garin N (2015) Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis. PLoS One 10:e0144032CrossRefPubMedPubMedCentral

11.

Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC (2016) Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest 149:209–219CrossRefPubMed

12.

Bi J, Yang J, Wang Y, Yao C, Mei J, Liu Y, Cao J, Lu Y (2016) Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis. PLoS One 11:e0165942CrossRefPubMedPubMedCentral

13.

Wu WF, Fang Q, He GJ (2017) Efficacy of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis. Am J Emerg Med. doi:10.1016/j.ajem.2017.07.050

14.

Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, Gabarrús A, Blum CA, Confalonieri M, Kasenda B, Siemieniuk RAC, Boersma W, Bos WJW, Christ-Crain M, Ovidius study group, Capisce study group, STEP study group (2017) Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data meta-analysis. Clin Infect Dis. doi:10.1093/cid/cix801

15.

Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, Briegel J, Carcillo J, Christ-Crain M, Cooper MS, Marik PE, Umberto MG, Olsen KM, Rodgers S, Russell JA, van den BG (2017) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. doi:10.1097/CCM.0000000000002737

16.

Menendez R, Martinez R, Reyes S, Mensa J, Filella X, Marcos MA, Martinez A, Esquinas C, Ramirez P, Torres A (2009) Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 64:587–591CrossRefPubMed

17.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrus A, Sellares J, Restrepo MI, Anzueto A, Niederman MS, Agusti C (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677–686CrossRefPubMed

Titel: Adjuvant therapies in critical care: steroids in community-acquired pneumonia
verfasst von: Antoni Torres
Miquel Ferrer
Michael S. Niederman
Publikationsdatum: 25.10.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 4/2018
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-017-4967-x

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Adjuvant therapies in critical care: steroids in community-acquired pneumonia

Excerpt

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Potential confounders affecting the reintubation rate

External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS

Emphysematous pyelonephritis class IV

Understanding therapeutic emergencies in acute hemolysis

What’s new in PICU in resource limited settings?

Bilateral basal ganglia abscesses in infectious endocarditis: an uncommon complication

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS